U
CYRN

UBS’s CYREN Ltd. CYRN Stock Holding History

UBS’s Portfolio CYRN Stock Details CYRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-43
Closed -$3K – 10946
2013
Q4 		$3K Buy
+43
New +$2.34K ﹤0.01% 9903
2013
Q3 		– Sell
-2
Closed – – 10803
2013
Q2 		$0 Buy
+2
New +$117 ﹤0.01% 10198

Other funds holding CYRN

GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

UBS's CYRN Position: Q1 2014 in Review

UBS sold out of CYREN Ltd. (CYRN) in Q1 2014, closing a stake of 43 shares — an estimated $3K sold.

UBS first reported a position in CYRN in Q2 2013 and held it in 2 quarters. The position peaked at $3K in Q4 2013. 12 funds tracked by Wall St. Rank hold CYRN as of Q1 2014.

  • UBS reported no remaining CYREN Ltd. position as of Q1 2014 after selling out during the quarter.
  • UBS sold 43 CYREN Ltd. shares in Q1 2014, an estimated $3K.
  • UBS first reported a position in CYREN Ltd. in Q2 2013 and held it in 2 quarters.
  • UBS's CYREN Ltd. position peaked at $3K in Q4 2013.
  • 12 funds tracked by Wall St. Rank held CYREN Ltd. as of Q1 2014.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.